187 related articles for article (PubMed ID: 23624389)
1. Regulation of bone morphogenetic protein signalling and cranial osteogenesis by Gpc1 and Gpc3.
Dwivedi PP; Grose RH; Filmus J; Hii CS; Xian CJ; Anderson PJ; Powell BC
Bone; 2013 Aug; 55(2):367-76. PubMed ID: 23624389
[TBL] [Abstract][Full Text] [Related]
2. Glypican-3 modulates inhibitory Bmp2-Smad signaling to control renal development in vivo.
Hartwig S; Hu MC; Cella C; Piscione T; Filmus J; Rosenblum ND
Mech Dev; 2005 Jul; 122(7-8):928-38. PubMed ID: 15925496
[TBL] [Abstract][Full Text] [Related]
3. Bone morphogenetic protein is required for fibroblast growth factor 2-dependent later-stage osteoblastic differentiation in cranial suture cells.
Jiang T; Ge S; Shim YH; Zhang C; Cao D
Int J Clin Exp Pathol; 2015; 8(3):2946-54. PubMed ID: 26045803
[TBL] [Abstract][Full Text] [Related]
4. Combined bone morphogenetic protein-2 and -7 gene transfer enhances osteoblastic differentiation and spine fusion in a rodent model.
Zhu W; Rawlins BA; Boachie-Adjei O; Myers ER; Arimizu J; Choi E; Lieberman JR; Crystal RG; Hidaka C
J Bone Miner Res; 2004 Dec; 19(12):2021-32. PubMed ID: 15537446
[TBL] [Abstract][Full Text] [Related]
5. FGF-, BMP- and Shh-mediated signalling pathways in the regulation of cranial suture morphogenesis and calvarial bone development.
Kim HJ; Rice DP; Kettunen PJ; Thesleff I
Development; 1998 Apr; 125(7):1241-51. PubMed ID: 9477322
[TBL] [Abstract][Full Text] [Related]
6. Alterations in mandibular morphology associated with glypican 1 and glypican 3 gene mutations.
Mian M; Ranjitkar S; Townsend GC; Anderson PJ
Orthod Craniofac Res; 2017 Aug; 20(3):183-187. PubMed ID: 28426184
[TBL] [Abstract][Full Text] [Related]
7. Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling.
Midorikawa Y; Ishikawa S; Iwanari H; Imamura T; Sakamoto H; Miyazono K; Kodama T; Makuuchi M; Aburatani H
Int J Cancer; 2003 Feb; 103(4):455-65. PubMed ID: 12478660
[TBL] [Abstract][Full Text] [Related]
8. Development of an efficient, non-viral transfection method for studying gene function and bone growth in human primary cranial suture mesenchymal cells reveals that the cells respond to BMP2 and BMP3.
Dwivedi PP; Anderson PJ; Powell BC
BMC Biotechnol; 2012 Aug; 12():45. PubMed ID: 22857382
[TBL] [Abstract][Full Text] [Related]
9. The BMP antagonist noggin regulates cranial suture fusion.
Warren SM; Brunet LJ; Harland RM; Economides AN; Longaker MT
Nature; 2003 Apr; 422(6932):625-9. PubMed ID: 12687003
[TBL] [Abstract][Full Text] [Related]
10. Bmp2 antagonizes sonic hedgehog-mediated proliferation of cerebellar granule neurones through Smad5 signalling.
Rios I; Alvarez-Rodríguez R; Martí E; Pons S
Development; 2004 Jul; 131(13):3159-68. PubMed ID: 15197161
[TBL] [Abstract][Full Text] [Related]
11. Glypican-based drug releasing titania implants to regulate BMP2 bioactivity as a potential approach for craniosynostosis therapy.
Bariana M; Dwivedi P; Ranjitkar S; Kaidonis JA; Losic D; Anderson PJ
Nanomedicine; 2018 Oct; 14(7):2365-2374. PubMed ID: 28648641
[TBL] [Abstract][Full Text] [Related]
12. Glypican-3 modulates BMP- and FGF-mediated effects during renal branching morphogenesis.
Grisaru S; Cano-Gauci D; Tee J; Filmus J; Rosenblum ND
Dev Biol; 2001 Mar; 231(1):31-46. PubMed ID: 11180950
[TBL] [Abstract][Full Text] [Related]
13. Boning up on glypicans--opportunities for new insights into bone biology.
Dwivedi PP; Lam N; Powell BC
Cell Biochem Funct; 2013 Mar; 31(2):91-114. PubMed ID: 23297043
[TBL] [Abstract][Full Text] [Related]
14. Expression and possible mechanisms of regulation of BMP3 in rat cranial sutures.
Nacamuli RP; Fong KD; Lenton KA; Song HM; Fang TD; Salim A; Longaker MT
Plast Reconstr Surg; 2005 Oct; 116(5):1353-62. PubMed ID: 16217479
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis in murine calvarial bone and suture development.
Rice DP; Kim HJ; Thesleff I
Eur J Oral Sci; 1999 Aug; 107(4):265-75. PubMed ID: 10467942
[TBL] [Abstract][Full Text] [Related]
16. Unravelling the molecular control of calvarial suture fusion in children with craniosynostosis.
Coussens AK; Wilkinson CR; Hughes IP; Morris CP; van Daal A; Anderson PJ; Powell BC
BMC Genomics; 2007 Dec; 8():458. PubMed ID: 18076769
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of posterofrontal/sagittal suture mesenchymal cells in vitro.
Xu Y; Malladi P; Chiou M; Longaker MT
Plast Reconstr Surg; 2007 Mar; 119(3):819-29. PubMed ID: 17312483
[TBL] [Abstract][Full Text] [Related]
18. Endogenous bone morphogenetic proteins in human bone marrow-derived multipotent mesenchymal stromal cells.
Seib FP; Franke M; Jing D; Werner C; Bornhäuser M
Eur J Cell Biol; 2009 May; 88(5):257-71. PubMed ID: 19303661
[TBL] [Abstract][Full Text] [Related]
19. BMP treatment of C3H10T1/2 mesenchymal stem cells induces both chondrogenesis and osteogenesis.
Shea CM; Edgar CM; Einhorn TA; Gerstenfeld LC
J Cell Biochem; 2003 Dec; 90(6):1112-27. PubMed ID: 14635186
[TBL] [Abstract][Full Text] [Related]
20. Differential activation of canonical Wnt signaling determines cranial sutures fate: a novel mechanism for sagittal suture craniosynostosis.
Behr B; Longaker MT; Quarto N
Dev Biol; 2010 Aug; 344(2):922-40. PubMed ID: 20547147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
